metaMe Health
Digital Therapy Fueled by Brainpower | CBInsights Top 150 Digital Health Companies | Sandoz HACk Winner
Digital Therapy Fueled by Brainpower | CBInsights Top 150 Digital Health Companies | Sandoz HACk Winner
metaMe Health is a digital therapy startup that focuses on developing FDA-cleared prescription digital therapeutics for the treatment of gastrointestinal conditions. Founded in 2016 and based in the United States, the company has gained recognition for its innovative approach, being named as one of the CBInsights Top 150 Digital Health Companies and winning the Sandoz HACk. With its flagship product, Regulora®, metaMe Health aims to revolutionize healthcare in the areas of Health Care, Health and Wellness, and Medical Devices. The company recently secured a $140.50K Debt Financing investment on 26th March 2024, signaling investor confidence in its potential to make a significant impact in the industry.
| Funding Stage | Amount | No. Investors | Investors | Date |
|---|---|---|---|---|
| Debt Financing | $140.50K | - | 26 Mar 2024 | |
| Debt Financing | $235.00K | - | 09 May 2023 | |
| Convertible Note | $2.20M | 1 |
|
15 Mar 2022 |
| Debt Financing | $65.00K | - | 09 Nov 2021 | |
| Seed Round | $3.80M | 3 |
|
05 Aug 2019 |
No recent news or press coverage available for metaMe Health.
We care about your data, and we'd love to use cookies make your experience better.
